Key Account Manager, Pharma & Biotech

MediSapiens Ltd.
Job Location
Erottajankatu 19 B
00130 Helsinki
Please, give your salary request
Job Description

Key Account Manager, Pharma & Biotech will be responsible for selling company’s solutions to world’s top pharmaceutical companies, ranging from big pharma to mid-sized biotechs.

Key tasks include:

  • Responsibility of the entire sales process, from prospecting to closing.
  • Contacting and selling company’s solutions to key persons in big and middle-sized pharmaceutical and biotech companies.
  • Traveling covers 50–60 % (100–120 days) of work time.
  • Key regions are Europe and the USA, but there are also business opportunities in Asia.


As Key Account Manager, you will work independently but in close collaboration with other members of the team. Your work will be essential in ensuring the future growth of company’s business within the pharma and biotech sector. The solutions you will sell help our customers in utilizing vast public or proprietary genomic datasets in their preclinical drug development process. This will eventually lead to better, personalized healthcare.

You will have no subordinates. This permanent position will preferably be located in company’s Helsinki office in city center. You will report to Chief Commercial Officer.


To succeed in this this job, we expect you to have:

  • Work experience in the pharmaceutical field or biotechnology, or in selling solutions for preclinical research.
  • Track record of 5–7 years in sales.
  • Understanding of the client segment and its challenges and needs.
  • Knowledge of the preclinical phase, i.e. development and research, in the pharmaceutical industry.
  • Readiness to travel (approx. 100–120 days / year).
  • Dynamic and hands-on working style.
  • Independent and self-motivated personality, but ability to be a team player and help others, too
  • Excellent command of English, other languages are an asset.
How to Apply

Send your application and CV with a salary request to no later than February 12th. For further information, contact Consultant Timo Jäntti: +358 40 171 2255, or CCO of MediSapiens Marko Kuisma, +358 50 377 3084 (only on Feb 9th at 1-3 pm Helsinki time (EET)).

About Our Organization

MediSapiens is a rapidly growing Finnish Bio-IT company with an international scope. MediSapiens develops innovative solutions for the effective use of genomic, clinical and biological data for its customers, who are leading companies and institutions in industry and healthcare. MediSapiens is shaping the digital revolution in healthcare with efficient use of data and is a leader in developing digital solutions that transform complex biological, genomic and clinical data into value. Already today, MediSapiens serves a variety of customers with web-based digital solutions: helping pharma companies develop better drugs, doctors make better treatment decisions and people and animals lead healthier lives.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.